NPI: 1427322411 · SACRAMENTO, CA 95815 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/08/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/08/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,584 | $1.30M |
| 2019 | 20,035 | $1.55M |
| 2020 | 16,204 | $652K |
| 2021 | 11,960 | $653K |
| 2022 | 8,296 | $393K |
| 2023 | 5,078 | $607K |
| 2024 | 3,680 | $688K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 46,430 | 4,492 | $5.68M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,102 | 1,270 | $112K |
| J1756 | Injection, iron sucrose, 1 mg | 7,230 | 1,926 | $27K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,705 | 1,316 | $17K |
| A4657 | Syringe, with or without needle, each | 2,833 | 963 | $15K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 110 | 65 | $852.97 |
| 90662 | 27 | 25 | $500.45 | |
| G0008 | Administration of influenza virus vaccine | 119 | 117 | $398.06 |
| 90674 | 63 | 62 | $111.89 | |
| 83970 | 314 | 285 | $111.03 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 113 | 47 | $84.00 |
| 82728 | 302 | 269 | $83.90 | |
| 83550 | 294 | 265 | $16.98 | |
| 82108 | 117 | 105 | $15.80 | |
| 83540 | 296 | 265 | $14.09 | |
| 85041 | 405 | 386 | $5.60 | |
| 85048 | 377 | 358 | $4.82 |